The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of cancer diagnosis, stage, and systemic therapies on immunogenicity after COVID-19 vaccination in patients with cancer: A systematic review and meta-analysis.
 
Guilherme Nader Marta
Travel, Accommodations, Expenses - Bayer; Roche
 
Chloe Spilleboudt
Consulting or Advisory Role - Abbvie
 
Diogo Martins-Branco
Honoraria - Merck Sharp & Dohme, Lda.; Novartis
Consulting or Advisory Role - Angelini Pharma Portugal, Unipessoal Lda; Janssen Cilag Farmacêutica, Lda; Merck Sharp & Dohme, Lda.; Pfizer
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen Cilag Farmacêutica, Lda; LEO Farmacêuticos; Merck Sharp & Dohme, Lda.; Novartis
 
Ana Tecic Vuger
Honoraria - Astellas Pharma; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer; Roche
Speakers' Bureau - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; PharmaSwiss; Roche
 
Veronique Debien
No Relationships to Disclose
 
Lieveke Ameye
No Relationships to Disclose
 
Mariana Brandão
Speakers' Bureau - Janssen (Inst); Roche/Genentech
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Sanofi; Takeda
 
Kevin Punie
Honoraria - Gilead Sciences (Inst); Lilly (Inst); Lilly (Inst); Mundipharma (Inst); Novartis (Inst); Novartis (Inst); Pfizer; Pfizer (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Lilly (Inst); Lilly (Inst); MSD (Inst); Novartis; Novartis; Novartis; Novartis (Inst); Novartis (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Teva (Inst); Vifor Pharma (Inst)
Research Funding - MSD (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche; Roche; Roche; Roche
 
Angela Loizidou
No Relationships to Disclose
 
Karen Willard-Gallo
Consulting or Advisory Role - Philips Healthcare
Research Funding - ITeos Therapeutics (Inst)
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Frame Therapeutics; Immunomedics; Immutep; Lilly; Menarini; MSD; NBE Therapeutics; Novartis; Odonate Therapeutics; Pfizer; Roche/Genentech; Seagen; Seagen
Research Funding - AstraZeneca (Inst); Immunomedics/Gilead (Inst); Lilly (Inst); Menarini (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - EU Cancer Mission Board; Oncolytics
 
Evandro de Azambuja
Honoraria - Libbs (Inst); Novartis/Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech; Seagen; Zodiac Pharma
Consulting or Advisory Role - Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche/Genentech